ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,096Medicare Part D Prescriptions Filled, Including Refills

Rank: 99 out of 1677

$830K Total Retail Price of All Prescriptions

Rank: 111 out of 1677

668 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 668 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 668 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 14,964 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 565 512 1 5
LISINOPRIL 494 440 2 3
AMLODIPINE BESYLATE 463 435 3 2
WARFARIN SODIUM 430 385 4 24
CITALOPRAM HBR 410 375 5 22
PRAVASTATIN SODIUM 395 362 6 10
METOPROLOL TARTRATE 394 354 7 12
NAMENDA 377 377 8 39
FUROSEMIDE 358 326 9 8
MIRTAZAPINE 340 329 10 62
DONEPEZIL HCL 324 313 11 30
GABAPENTIN 313 275 12 11
HYDROCODONE-ACETAMINOPHEN 301 293 S3 13 4
SIMVASTATIN 299 237 14 1
FAMOTIDINE 296 228 15 41
RANITIDINE HCL 271 227 16 18
HYDROCHLOROTHIAZIDE 263 237 17 9
POTASSIUM CHLORIDE 235 199 18 14
OMEPRAZOLE 228 193 19 6
TRAMADOL HCL 225 189 20 16
RISPERIDONE 216 214 21 60
LOSARTAN POTASSIUM 207 206 22 25
POLYETHYLENE GLYCOL 3350 188 155 23 76
SERTRALINE HCL 185 156 24 26
CLONIDINE HCL 163 154 25 36
LANTUS 161 138 26 44
ZOLPIDEM TARTRATE 157 129 27 15
LIDODERM 150 149 28 160
QUETIAPINE FUMARATE 147 133 29 77
METFORMIN HCL 143 96 30 7
CYMBALTA 138 116 31 58
ALLOPURINOL 121 105 32 31
CARVEDILOL 118 103 33 20
PANTOPRAZOLE SODIUM 115 99 34 46
CLOPIDOGREL 111 97 35 32
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 91 36 85
CARBIDOPA-LEVODOPA 104 104 37 131
ALBUTEROL SULFATE 99 94 38 135
TAMSULOSIN HCL 97 70 39 34
NORTRIPTYLINE HCL 96 80 40 206
METOPROLOL SUCCINATE 95 73 41 23
ISOSORBIDE MONONITRATE ER 94 86 42 73
TRAZODONE HCL 93 90 43 37
DIVALPROEX SODIUM 92 74 44 111
CEFTRIAXONE 90 88 45 242
ROPINIROLE HCL 89 74 46 79
FLUTICASONE PROPIONATE 88 77 47 29
DIOVAN 87 74 48 45
CIPROFLOXACIN HCL 86 84 49 57
LEVOFLOXACIN 83 81 50 84
OXYBUTYNIN CHLORIDE 82 53 51 149
DOXYCYCLINE HYCLATE 82 71 51 96
LOVASTATIN 80 76 53 35
CHLORTHALIDONE 79 62 54 137
ESCITALOPRAM OXALATE 78 50 55 80
ALENDRONATE SODIUM 73 61 56 43
PROMETHAZINE HCL 73 68 R 56 64
EXELON 72 72 58 119
FENTANYL 72 49 S2 58 103
IPRATROPIUM BROMIDE 71 71 60 171
SPIRIVA 70 64 61 74
OXYCODONE-ACETAMINOPHEN 67 64 S2 62 122
HYDRALAZINE HCL 67 58 62 69
ADVAIR DISKUS 65 52 64 54
DIGOXIN 64 61 65 71
MORPHINE SULFATE ER 62 42 S2 66 140
SEROQUEL 62 57 66 151
PLAVIX 61 53 68 47
TRICOR 59 49 69 100
LEVETIRACETAM 59 48 69 116
BUSPIRONE HCL 59 52 69 120
IPRATROPIUM-ALBUTEROL 59 59 69 197
DILTIAZEM HCL 58 53 73 218
DICLOFENAC SODIUM 58 46 73 95
ATENOLOL 57 40 75 21
PAROXETINE HCL 57 56 75 67
ADVAIR HFA 56 54 77 258
FINASTERIDE 54 54 78 130
MORPHINE SULFATE 54 37 S2 78 273
SPIRONOLACTONE 51 45 80 88
TRIAMCINOLONE ACETONIDE 51 40 80 134
OLANZAPINE 50 48 82 189
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.